Massive Transfusion and Blood Product Dynamics in Obstetric Hysterectomy: A One-Year Prospective Study from a Tertiary Care Centre in North India

Authors

  • Verma K Department of Obstetrics and Gynecology, Government Medical College, Patiala, Punjab, India
  • Kaur SP Department of Obstetrics and Gynecology, Government Medical College, Patiala, Punjab, India
  • Kaur P Department of Obstetrics and Gynecology, Government Medical College, Patiala, Punjab, India

Keywords:

Massive transfusion, Obstetric hysterectomy, Post partum hemorrhage, Placenta accreta, Blood transfusion practice

Abstract

Obstetric hysterectomy (OH) is a maternal near-miss event most often required for catastrophic obstetric hemorrhage, with blood transfusion being unavoidable. This prospective observational study conducted over one year (February 2023–January 2024) at a
tertiary care center in North India evaluated blood and blood product utilization and maternal outcomes in women undergoing OH. Among 3,759 deliveries, 37 women underwent OH (incidence 9.84/1,000), with placenta accreta spectrum being the leading indication (64.8%). All patients required packed red blood cell transfusion (mean 4–6 units), while fresh frozen plasma, platelets, and cryoprecipitate were used in 50%, 20%, and 6.6% of cases, respectively. Maternal deaths occurred only in cases requiring massive transfusion (>10 PRBC units), predominantly associated with PAS. The study emphasizes that optimal transfusion support, early activation of massive transfusion protocols, and blood bank preparedness are critical for improving outcomes in obstetric hysterectomy, especially in resource-limited settings.

Downloads

Download data is not yet available.

References

1. Knight M. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG. 2007;114(11):1380–7.

2. Briery CM, Rose CH, Hudson WT, Lutgendorf MA, Magann EF, Chauhan SP, Morrison JC. Planned versus emergent cesarean hysterectomy: maternal morbidity and mortality. Am J Obstet Gynecol. 2007;197(2):154.e1–5.

3. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–4.

4. Khan B, Sultana R, Bashir R, Deeba F. A ten year review of emergency peripartum hysterectomy in a tertiary care hospital. J Ayub Med Coll Abbottabad. 2012;24(1):14–7.

5. Sholapurkar SL. Massive obstetric haemorrhage and emergency hysterectomy: lessons from maternal deaths. Obstet Med. 2017;10(3):121–7.

6. Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018;140(3):291–8.

7. Vogel JP, Williams M, Gallos I, Althabe F, Oladapo OT. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? BMJ Glob Health. 2019;4(2):e001466.

Downloads

Published

01-01-2026

How to Cite

Verma, K., Kaur, S. P., & Kaur, P. (2026). Massive Transfusion and Blood Product Dynamics in Obstetric Hysterectomy: A One-Year Prospective Study from a Tertiary Care Centre in North India. GMC Patiala Journal of Research and Medical Education, 8(02), 15–17. Retrieved from https://jrme.gmcpatiala.edu.in/index.php/j/article/view/209

Issue

Section

Original Research Articles